PCH vs TECH · P/E 51, rev $1.06B vs P/E 65, rev $1.22B
PotlatchDeltic Corp (PCH) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
PotlatchDeltic Corp (PCH) is a reit - specialty company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported PCH revenue for 2024-12-31 was $1.06B. Net income was $21.9M. Revenue was up 3.7% from 2023-12-31 to 2024-12-31. PCH currently screens at market cap $3.23B and trailing P/E 50.9.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
PCH currently screens at market cap $3.23B and trailing P/E 50.9. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the PCH and TECH stock pages for the full models.
Not investment advice.